WntResearch files a patent application for the treatment of Acute Myeloid Leukemia
WntResearch announces today that the company has filed a new patent application that broadly covers the use of Foxy-5 in the treatment of Acute Myeloid Leukemia (AML).In a research exchange with a Brazilian research group at the Hematology and Transfusion Medicine Center at University of Campinas/Hemocentro-UNICAMP in São Paulo, WNT Research has provided Foxy-5 and expertise of its use in the experimental studies. In exchange the company has secured that all intellectual property rights accrue WNTResearch based on the research group’s research with Foxy-5 on AML cells. The research